Europe joins forces to tackle COVID-19
Convalescent plasma (CP) from recovered COVID-19 patients is being considered as a potential treatment. The EU-funded SUPPORT-E project aims to support high quality clinical evaluation of COVID-19 CP as well as data collection and analysis. It also strives to improve CP potency assessment, develop evidence-based recommendations on the appropriate use of CP for the treatment of COVID-19 across EU Member States and promote best practices regarding CP collection and use in the current health crisis as well as in subsequent crises involving novel pathogens. By bringing together major European blood establishments with world leading research capabilities, SUPPORT-E constitutes the first EU coordinated research effort to support high quality clinical and scientific evaluation of COVID-19 CP.
Call for proposal
See other projects for this call
Funding SchemeRIA - Research and Innovation action
93210 La Plaine Saint Denis